Skip to main content

Table 3 Subgroup analyses of the included studies

From: The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis

Subgroup analyses

n (%)

P (95% CI)

I2 (%)

P-value

Sensitivity (95% CI)

Specificity (95% CI)

PLR (95% CI)

NLR (95% CI)

DOR (95% CI)

AUC

Sample size

 ≤ 100

9 (75)

0.31 (0.23–0.41)

81.72

< 0.001

0.85 (0.82–0.88)

0.78 (0.60–0.75)

2.72 (1.98–3.75)

0.11 (0.32–0.40)

26.44 (5.41–129.09)

0.63

 > 100

3 (25)

0.41 (0.28–0.56)

52.94

0.231

0.69 (0.60–0.76)

0.68 (0.66–0.71)

2.139 (1.07–4.25)

0.35 (0.089–1.37)

7.03 (0.917–53.46)

0.61

Ethnicity

 Asian

8 (66)

0.32 (0.23–0.42)

85.22

< 0.001

0.91 (0.87–0.93)

0.70 (0.66–0.72)

3.048 (2.681–3.46)

0.07 (0.015–0.34)

45.42 (7.63–270.56)

0.55

 Caucasian

4 (34)

0.38 (0.26–0.52)

44.27

0.088

0.72 (0.67–0.77)

0.67 (0.62–0.71)

2.189 (1.23–3.88)

0.29 (0.095–0.89)

9.31 (1.73–50.1)

0.75

Detection methods

 PAS+

4 (34)

0.40 (0.30–0.52)

35.04

0.097

0.75 (0.69–0.81)

0.69 (0.65–0.72)

0.09 (0.018–0.47)

2.98 (2.61–3.41)

34.34 (5.12–230.22)

0.75

 PAS + CD31-

5 (41)

0.24 (0.15–0.35)

84.55

< 0.001

0.9 (0.86–0.92)

0.70 (0.64–0.75)

2.36 (1.2–4.64)

0.29 (0.073–1.17)

9.24 (1.22–69.99)

0.60

 PAS + CD34-

3 (25)

0.39 (0.27–0.42)

59.52

0.081

0.73 (0.66–0.79)

0.66 (0.59–0.72)

2.37 (0.92–6.14)

0.07 (0.01–37.37)

33.43 (0.12–92.24)

0.46

Total

 12 (100)

0.35 (0.27–0.42)

79.75

< 0.001

0.82 (0.79–0.84)

0.69 (0.66–0.71)

2.56 (1.94–3.93)

0.17 (0.065–0.42)

17.75 (5.301–59.44)

0.629

  1. Abbreviations: PAS Periodic acid schiff’s, n Number, P Proportion, 95% CI 95% confidence intervals, PLR Positive likelihood ratio, NLR Negative likelihood ratio, DOR Diagnostic odds ratio, AUC Area under the characteristic